- Home
- MRK vs SHEL Comparison
MRK vs SHEL Comparison
Compare MRK & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- SHEL
- Stock Information
- Founded
- MRK 2000
- SHEL 1907
- Country
- MRK United States
- SHEL United Kingdom
- Employees
- MRK N/A
- SHEL N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- SHEL Oil & Gas Production
- Sector
- MRK Health Care
- SHEL Energy
- Exchange
- MRK Nasdaq
- SHEL Nasdaq
- Market Cap
- MRK 218.8B
- SHEL 215.9B
- IPO Year
- MRK N/A
- SHEL N/A
- Fundamental
- Price
- MRK $91.49
- SHEL $76.49
- Analyst Decision
- MRK Buy
- SHEL Buy
- Analyst Count
- MRK 15
- SHEL 9
- Target Price
- MRK $105.29
- SHEL $80.76
- AVG Volume (30 Days)
- MRK 10.7M
- SHEL 4.3M
- Earning Date
- MRK 10-30-2025
- SHEL 10-30-2025
- Dividend Yield
- MRK 3.56%
- SHEL 3.75%
- EPS Growth
- MRK 58.08
- SHEL N/A
- EPS
- MRK 7.56
- SHEL 2.42
- Revenue
- MRK $64,235,000,000.00
- SHEL $269,075,000,000.00
- Revenue This Year
- MRK $1.82
- SHEL N/A
- Revenue Next Year
- MRK $5.10
- SHEL N/A
- P/E Ratio
- MRK $12.04
- SHEL $31.59
- Revenue Growth
- MRK 1.68
- SHEL N/A
- 52 Week Low
- MRK $73.31
- SHEL $58.55
- 52 Week High
- MRK $105.07
- SHEL $77.47
- Technical
- Relative Strength Index (RSI)
- MRK 67.81
- SHEL 61.72
- Support Level
- MRK $82.01
- SHEL $74.30
- Resistance Level
- MRK $88.30
- SHEL $77.47
- Average True Range (ATR)
- MRK 2.18
- SHEL 0.87
- MACD
- MRK 0.47
- SHEL 0.16
- Stochastic Oscillator
- MRK 87.57
- SHEL 76.48
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.